HANSOH PHARMA 03692Hong Kong Stock Exchange

31.5401.99%( -0.640 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
HANSOH PHARMA (03692) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2019-06-14
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
KYG549581067
Southbound Connect
Shanghai · Shenzhen

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)17.62B12/112
Net Profit (Last FY)6.51B6/125
ROE (Last FY)15.71%14/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
Zhong Huijuan Executive Director
Sun Yuan Executive Director
Lyu Aifeng Executive Director
Lin Guoqiang Independent Non-Executive Director
Chan Charles Sheung Wai Independent Non-Executive Director
Yang Dongtao Independent Non-Executive Director
Yan Jia Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2025-12-28.

About this page

This page shows HANSOH PHARMA (03692) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.